About Nu Vision
Nu Vision is a company based in Nottingham (United Kingdom) founded in 2015.. Nu Vision has raised $13.39 million across 6 funding rounds from investors including Mercia, Newable and The University of Nottingham. Nu Vision offers products and services including Omnigen and OmniLenz. Nu Vision operates in a competitive market with competitors including Imbed Biosciences, MiMedx Group, Cresilon, Kane Biotech and BioTissue, among others.
- Headquarter Nottingham, United Kingdom
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Nuvision Biotherapies Limited
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$13.39 M (USD)
in 6 rounds
-
Latest Funding Round
$6.57 M (USD), Series B
Feb 05, 2026
-
Investors
Mercia
& 7 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nu Vision
Nu Vision offers a comprehensive portfolio of products and services, including Omnigen and OmniLenz. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Natural amniotic membrane dressing for ocular wound healing and recovery.
Bespoke lens for rapid, surgery-free ocular care and treatment.
Unlock access to complete
Unlock access to complete
Funding Insights of Nu Vision
Nu Vision has successfully raised a total of $13.39M across 6 strategic funding rounds. The most recent funding activity was a Series B round of $6.57 million completed in February 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series B — $6.6M
-
First Round
First Round
(29 Jul 2015)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2026 | Amount | Series B - Nu Vision | Valuation | Mercia Ventures | |
| Mar, 2023 | Amount | Series A - Nu Vision | Valuation | The University of Nottingham | |
| Jul, 2021 | Amount | Series A - Nu Vision | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Nu Vision
Nu Vision has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Mercia, Newable and The University of Nottingham. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment funding is provided to support Midlands SMEs growth.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Life Science focused startup accelerator and incubator
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Nu Vision
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Nu Vision
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nu Vision Comparisons
Competitors of Nu Vision
Nu Vision operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Imbed Biosciences, MiMedx Group, Cresilon, Kane Biotech and BioTissue, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Nanotech-based wound care products are developed and provided.
|
|
| domain | founded_year | HQ Location |
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics
|
|
| domain | founded_year | HQ Location |
Developer of hemostatic products for wound care
|
|
| domain | founded_year | HQ Location |
Therapeutic solutions for biofilm prevention and removal are developed.
|
|
| domain | founded_year | HQ Location |
Regenerative biologic therapies for eye care are developed and provided.
|
|
| domain | founded_year | HQ Location |
Biomaterials and devices for internal wound healing are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Nu Vision
Frequently Asked Questions about Nu Vision
When was Nu Vision founded?
Nu Vision was founded in 2015.
Where is Nu Vision located?
Nu Vision is headquartered in Nottingham, United Kingdom.
Is Nu Vision a funded company?
Nu Vision is a funded company, having raised a total of $13.39M across 6 funding rounds to date. The company's 1st funding round was a Series A of $2.49M, raised on Jul 29, 2015.
What does Nu Vision do?
NuVision was founded in 2015 in Nottingham, United Kingdom, within the biotechnology sector focused on ophthalmic care. Regenerative wound dressings are developed for the eyes surface, including Omnigen, a dry preserved biological matrix derived from human amniotic membrane used in wound care. An OmniLenz bandage contact lens is also provided for suture-free transplantation. Operations center on biological matrix preservation and application in eye regeneration.
Who are the top competitors of Nu Vision?
Nu Vision's top competitors include Imbed Biosciences, MiMedx Group and Cresilon.
What products or services does Nu Vision offer?
Nu Vision offers Omnigen and OmniLenz.
Who are Nu Vision's investors?
Nu Vision has 8 investors. Key investors include Mercia, Newable, The University of Nottingham, BioCity, and Midlands Engine Investment Fund.